Aktie LA JOLLA PHARMACEUTICAL COMPANY
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen La Jolla Pharmaceutical Company OTC Bulletin Board

Aktien

US5034596040

Schlusskurs OTC Bulletin Board
Andere Börsenplätze
- USD - Intraday Chart für La Jolla Pharmaceutical Company
2022 La Jolla Pharmaceutical gibt Änderungen im Management bekannt CI
2022 Innoviva, Inc. (NasdaqGS:INVA) hat die Übernahme von La Jolla Pharmaceutical Company (NasdaqCM:LJPC) abgeschlossen. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
La Jolla Pharmaceutical Announces Management Changes
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index
Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.
La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
Twitter, Las Vegas Sands fall; Mullen, La Jolla rise
Sector Update: Health Care Stocks Edging Lower at Close
Top Midday Gainers
Sector Update: Health Care Stocks Still Little Changed
Sector Update: Health Care
Innoviva Agrees to Take La Jolla Pharmaceutical Private in $149 Million Acquisition Deal; Shares Rise
La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K
LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
Innoviva to Acquire La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company Equity Buyback announced on November 17, 2021, has expired, in connection with the announced merger, the stock repurchase plan was cancelled effective July 11, 2022.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1XB6B Aktie
  4. Aktie
  5. Nachrichten La Jolla Pharmaceutical Company
  6. Andere Sprachen